Back to results
US 2026/0294833 A1Published application
Pharmaceutical Composition of Siglec-Binding Agents
AssigneeCytodigm, Inc.
InventorsBin WU, Zimeng WANG, Nicholas J. BOYLAN, Jieni XU
Life of this patent
Estimating the term…
Abstract
This invention provides a pharmaceutical composition comprising an agent that can bind Siglec receptors on cell surface. This invention also provides the method of preparing said pharmaceutical composition and the use thereof.
Claims19
A composition comprising nanoparticles comprising a polysialic acid co-precipitated with an ionizable lipid or polymer and an optional active pharmaceutical ingredient.
Dependencies are inferred from the claim text.